NAP1L1 Inhibitors
NAP1L1 inhibitors belong to a specialized class of chemical compounds designed to target the NAP1L1 (Nucleosome Assembly Protein 1-Like 1) protein, which is also known as NAP1 or hNAP1. NAP1L1 is a multifunctional protein that plays a crucial role in chromatin dynamics and the assembly of nucleosomes, which are the fundamental repeating units of chromatin structure. Chromatin consists of DNA wrapped around histone proteins, and nucleosome assembly is a dynamic process that regulates access to genetic information and gene expression. NAP1L1, as a histone chaperone, interacts with histone proteins and facilitates the deposition of histones onto DNA during nucleosome formation and disassembly.
Inhibitors of NAP1L1 are designed to interact with this protein and disrupt its histone binding or chaperone activity. These inhibitors may operate through various mechanisms, such as binding to specific domains of NAP1L1 or altering its conformation. By inhibiting NAP1L1, these compounds can interfere with the proper assembly and disassembly of nucleosomes, affecting chromatin structure and DNA accessibility. Research on NAP1L1 inhibitors is primarily focused on elucidating the molecular mechanisms by which NAP1L1 contributes to nucleosome dynamics and chromatin organization, offering insights into the intricate processes that govern gene regulation and chromatin structure within the cell. Understanding the functions of NAP1L1 has broader implications for our knowledge of epigenetic regulation and gene expression control.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, which could decrease NAP1L1 transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to intercalate into DNA, which may affect gene expression, potentially reducing NAP1L1 levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that has been shown to reduce transcription levels of various genes. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
An inhibitor of DNA polymerase, which could lead to a decrease in DNA replication-dependent gene expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor which could affect multiple signaling pathways, potentially altering NAP1L1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could affect signaling pathways and potentially decrease NAP1L1 transcription. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
A DNA intercalating agent that may impede transcription factor binding, potentially reducing NAP1L1 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that affects NF-κB pathway and can lead to altered gene expression including NAP1L1. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A hypomethylating agent that could affect DNA methylation and gene expression, potentially influencing NAP1L1 levels. | ||||||